Quality of Life Under Extended Continuous Versus Intermittent Adjuvant Letrozole in Lymph Node-Positive, Early Breast Cancer Patients: The SOLE Randomised Phase 3 Trial
British Journal of Cancer - United Kingdom
doi 10.1038/s41416-019-0435-4
Full Text
Open PDFAbstract
Available in full text
Date
April 10, 2019
Authors
Publisher
Springer Science and Business Media LLC